High blood pressure and chronic kidney disease are associated with a higher incidence of retinopathy in subjects who are not diabetic, a study found.
Iluvien For Diabetic Macular Edema Turned Down By FDA
Investigational drug Iluvien (fluocinolone acetonide intravitreal insert) for the treatment of diabetic macular edema cannot be approved in its present form, the FDA (Food and Drug Administration) wrote in its Complete Response Letter (CRL). Illuven is…
Santen files IND for Clinical Data’s ATL313 for primary open angle glaucoma and ocular hypertension
Clinical Data, Inc., today announced that Santen Pharmaceutical Co., Ltd., has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for Clinical Data’s highly selective adenosine A2A agonist, ATL313, for …
Enrollment begins in Phase 2 trial of RegeneRx’s RGN-259 in dry eye associated with graft vs. host disease
RegeneRx Biopharmaceuticals, Inc. announced today that the first patient has been screened and is being enrolled in a Phase 2 clinical trial testing the Company’s drug candidate RGN-259 in patients with dry eye associated with graft vs. host disease. T…
Posterior Capsule Plaque Often Observed In Pediatric Cataractous Eyes
Posterior capsule plaque occurred frequently in pediatric eyes with cataract but did not significantly affect the outcomes of IOL implantation, a study said.
Posterior Capsule Plaque Often Observed In Pediatric Cataractous Eyes
Posterior capsule plaque occurred frequently in pediatric eyes with cataract but did not significantly affect the outcomes of IOL implantation, a study said.